Aria Pharmaceuticals Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Out of Business

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Out of Business

Aria Pharmaceuticals General Information

Description

Operator of an artificial intelligence-driven drug discovery firm intended to build a pipeline of therapeutic candidates. The company's firm leverages a computational platform to identify promising drug candidates, de-risks the opportunities through preclinical studies and progresses drug candidates to the clinic through industry and investor partnerships, enabling pharmaceutical companies to boost the traditional methods of drug discovery for rare diseases.

Contact Information

Website
www.ariapharmaceuticals.com
Formerly Known As
twoXAR Pharmaceuticals, twoXAR
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 265 Cambridge Avenue
  • Suite 60099
  • Palo Alto, CA 94306
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, TMT, HealthTech, Life Sciences
Corporate Office
  • 265 Cambridge Avenue
  • Suite 60099
  • Palo Alto, CA 94306
  • United States
+1 (650)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aria Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 27-Sep-2023 Completed Pre-Clinical Trials
6. Later Stage VC (Series B) 01-Aug-2021 Completed Pre-Clinical Trials
5. Debt - PPP 16-Apr-2020 Completed Pre-Clinical Trials
4. Grant 28-Nov-2018 Completed Pre-Clinical Trials
3. Early Stage VC (Series A) 19-Mar-2018 Completed Pre-Clinical Trials
2. Seed Round 06-Nov-2015 $4.31M $4.31M Completed Pre-Clinical Trials
1. Accelerator/Incubator 24-Jun-2015 Completed Pre-Clinical Trials
To view Aria Pharmaceuticals’s complete valuation and funding history, request access »

Aria Pharmaceuticals Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A
Seed 3,655,892 $0.000100 $0.07 $1.24 $1.24 1x $1.24 11.89%
To view Aria Pharmaceuticals’s complete cap table history, request access »

Aria Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an artificial intelligence-driven drug discovery firm intended to build a pipeline of therapeutic candidates
Drug Discovery
Palo Alto, CA
11 As of 2023

Nottingham, United Kingdom
 

New Haven, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aria Pharmaceuticals Competitors (29)

One of Aria Pharmaceuticals’s 29 competitors is Sygnature Discovery, a Private Equity-Backed company based in Nottingham, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sygnature Discovery Private Equity-Backed Nottingham, United Kingdom
OrphAI Therapeutics Venture Capital-Backed New Haven, CT
KineMed Formerly VC-backed Emeryville, CA
BenevolentAI Formerly PE-Backed London, United Kingdom
Recursion Pharmaceuticals Formerly VC-backed Salt Lake City, UT
You’re viewing 5 of 29 competitors. Get the full list »

Aria Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Aria Pharmaceuticals FAQs

  • When was Aria Pharmaceuticals founded?

    Aria Pharmaceuticals was founded in 2014.

  • Where is Aria Pharmaceuticals headquartered?

    Aria Pharmaceuticals is headquartered in Palo Alto, CA.

  • What is the size of Aria Pharmaceuticals?

    Aria Pharmaceuticals has 11 total employees.

  • What industry is Aria Pharmaceuticals in?

    Aria Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Aria Pharmaceuticals a private or public company?

    Aria Pharmaceuticals is a Private company.

  • What is Aria Pharmaceuticals’s current revenue?

    The current revenue for Aria Pharmaceuticals is .

  • How much funding has Aria Pharmaceuticals raised over time?

    Aria Pharmaceuticals has raised $54.3M.

  • Who are Aria Pharmaceuticals’s competitors?

    Sygnature Discovery, OrphAI Therapeutics, KineMed, BenevolentAI, and Recursion Pharmaceuticals are some of the 29 competitors of Aria Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »